Arizona State University
337
48
62
222
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.8%
23 terminated/withdrawn out of 337 trials
90.6%
+4.1% vs industry average
2%
8 trials in Phase 3/4
16%
36 of 222 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (337)
The Impact of Self-assessment on Hydration
Role: lead
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Role: lead
Increasing Physical Activity Through Social Support and Stress Resilience
Role: lead
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
Role: lead
Brain Mechanisms of Reducing Polysubstance Use
Role: lead
Informational Nudge to Improve Heart Failure Prescribing
Role: collaborator
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
Role: lead
Drumming Groups for Parents of Autistic Children
Role: lead
Proactive Speech and Language Intervention for Infants With Down Syndrome
Role: lead
Factorial Optimization Trial to Test Effects of Coping Intervention Components
Role: lead
Parenting in 2 Worlds Multisite Trial
Role: lead
Light Exposure, Migraine Outcomes, and Sleep Quality
Role: lead
Personalized Approach to Promote Healthy Aging
Role: lead
Adjunctive Bright Light Therapy for Opioid Use Disorder
Role: lead
Preventing Diabetes in Latino Families
Role: lead
Mindfulness-Based Ecological Momentary Intervention for Opioid Use Disorder and Chronic Pain
Role: lead
Vancomycin for Primary Sclerosing Cholangitis
Role: collaborator
Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
Role: lead
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Role: collaborator
Acute Kidney Injury and Ultra-endurance Running
Role: lead